indoximod
Term · Oncology and biomedicine · MLC-T-ONC-014445
A methylated tryptophan with immune checkpoint inhibitory activity. Indoximod inhibits the enzyme indoleamine 2,3-dioxygenase (IDO), which degrades the essential amino acid tryptophan, and may increase or maintain tryptophan levels important to T cell function. Tryptophan depletion is associated with immunosuppression involving T cell arrest and anergy.
| Identifier | MLC-T-ONC-014445 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | 1-MT |
| Synonyms | 1-methyl-d-tryptophan; D-(+)-1-methyltryptophan; D-1MT |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014445",
"term": "indoximod",
"field": "Oncology and biomedicine",
"definition": "A methylated tryptophan with immune checkpoint inhibitory activity. Indoximod inhibits the enzyme indoleamine 2,3-dioxygenase (IDO), which degrades the essential amino acid tryptophan, and may increase or maintain tryptophan levels important to T cell function. Tryptophan depletion is associated with immunosuppression involving T cell arrest and anergy.",
"abbreviation": "1-MT",
"synonyms": [
"1-methyl-d-tryptophan",
"D-(+)-1-methyltryptophan",
"D-1MT"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/indoximod/"
}
Record 9,225 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.